Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 21 | 19 | −2 |
| Shares | 1.08M | 834.5K | −241.1K (−22.4%) |
| Value | $3.58M | $1.30M | −$2.28M (−63.6%) |
New holders (4)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Investments, LP | 104,120 | $162.0K | 0.00% |
| Citadel Advisors LLC | 68,970 | $107.0K | 0.00% |
| Simplex Trading, LLC | 9,883 | $15.0K | 0.00% |
| Cutler Group LP | 400 | $0 | 0.00% |
Sold out (6)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Schonfeld Strategic Advisors LLC | 342,900 | $1.14M |
| Susquehanna International Group, LLP | 67,640 | $225.0K |
| Virtu Financial LLC | 53,019 | $177.0K |
| Squarepoint Ops LLC | 35,814 | $119.0K |
| Northern Trust Corp | 13,705 | $46.0K |
| Two Sigma Securities, LLC | 10,494 | $35.0K |